Omicron aims at delivering top quality consultancy within biostatistics, statistical programming, epidemiology, real-world evidence and register-based research. Omicron is a member of the Danish Society for Biopharmaceutical Statistics. We are financially supporting the R-project and will continue to promote the use of R within clinical development
I have been involved in a number of research projects where the results have been published